Antithrombotic therapy in very elderly patients with atrial fibrillation: is it enough to assess thromboembolic risk?

Clinical interventions in aging

Volumn 5, Issue , 2010, Pages 157-162

  Guo, Yutao ^a   Wu, Qiang ^b   Zhang, L ^b   Yang, Tingshu ^b   Zhu, Ping ^b   Gao, Wenqian ^b   Zhao, Yuexiang ^b   Gao, Meng ^b  

^a General Hospital of the Chinese PLA Beijing Region   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

AGED; BLEEDING; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; THROMBOSIS;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; MALE; RISK ASSESSMENT; THROMBOSIS;

MLCS; MLOWN;

EID: 77955302969     PISSN: None     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/cia.s9399     Document Type: Review

References (18)